Eric Marsault

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 8 CIPO patents and 7 EPO patents, primarily in Macrocyclic Compounds. Top assignees: Ocera Therapeutics, Inc., Mcgill University, Socpra Sciences Sante Et Humaines S.e.c.. Active years: 1998-2019.

USPTO Granted Patents = 24 (Patent Applications = 3)

% Patents Active = 70.8

CIPO Patents = 8 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 247(Granted Patents)

Location History:

Montreal, CA (1998 - 2003)
Québec, CA (2012 - 2015)
Sherbrooke, CA (2000 - 2019)

Company Filing History:

8 out of 27

Ocera Therapeutics, Inc.

Socpra Sciences Sante Et Humaines S.e.c.

Socpra Sciences Et Genie S.e.c.

patents

6. 1 out of 1,035

Isis Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

Areas of Expertise:

Macrocyclic Compounds

Ghrelin Receptor Modulators

Matriptase Inhibitors

Antibiotics

Steroid Alkaloids

Phosphorothioate Oligomers

Motilin Antagonists

Biologically Active Molecules

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10258602 - Macrocyclic ghrelin receptor modulators and methods of using the same (2019-04-16),

2. 10208308 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections (2019-02-19),

3. 10040751 - Intermediates for macrocyclic compounds (2018-08-07),

4. 9993491 - Guanine riboswitch binding compounds and their use as antibiotics (2018-06-12),

5. 9949949 - Macrocyclic ghrelin receptor modulators and methods of using the same (2018-04-24),

6. 9752149 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections (2017-09-05),

7. 9493505 - Macrocyclic modulators of the ghrelin receptor (2016-11-15),

8. 9457033 - Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria (2016-10-04),

9. 9371297 - Macrocyclic ghrelin receptor modulators and methods of using the same (2016-06-21),

10. 9365853 - Matriptase inhibitors and uses thereof against orthomyxoviridae infections (2016-06-14),

11. 9181298 - Intermediates for macrocyclic compounds (2015-11-10),

12. 9133235 - Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders (2015-09-15),

13. 8921521 - Macrocyclic modulators of the Ghrelin receptor (2014-12-30),

14. 8334256 - Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor (2012-12-18),

15. 8129561 - Processes for intermediates for macrocyclic compounds (2012-03-06),

Title: The Innovative Journey of Eric Marsault

Introduction: Eric Marsault, a visionary inventor hailing from Sherbrooke, Canada, has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Eric Marsault's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Eric Marsault has established himself as a pioneer in the field of technology. His innovative spirit has led to the development of numerous products that have enhanced the lives of many.

Collaborations: Throughout his career, Eric Marsault has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: Eric Marsault's passion for innovation and his relentless drive to push the boundaries of technology have solidified his position as a respected inventor in the industry. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.